Newsletter | April 8, 2026

04.08.26 -- STREAM Edition: Layering In AI Technology To Improve Your Clinical Trial

RTSM Reusability Matters When Teams Change

Video | Korio

Explore critical considerations for organizations that felt the impact of staff turnover on RTSM execution.

The Difference Between Clinical Trial Auditing And Monitoring

Video | BRANY

While both trial auditing and trial monitoring have the same goal of protecting participant safety and rights, they are two separate yet important pieces of the clinical trial process.

The Rise Of The Site: Empowering Efficient Clinical Study Execution

Webinar | CRIO

Join the Co-CEO of CRIO, as he explores research site challenges and how site-based technologies can reduce administrative burdens, enhance efficiency, and eliminate redundant one-time-use technologies.

Why Functional Outsourcing Is Important To Clinical Development

Video | Worldwide Flex

Craig McIlloney, Senior VP of Worldwide Flex, discusses why functional outsourcing is important in today's clinical development environment, how Worldwide Flex is scalable to your changing needs.

Accelerating Data Cleaning

Video | PPD Clinical Research Business of Thermo Fisher Scientific

AI-enabled clinical trial technology enables faster processing of large data volumes, thereby enhancing workflows, easing the burden on busy trial teams, and protecting patients.

Accelerate Clinical Insights: From Data Deluge To Decisions In Minutes

Video | Revvity Signals Software, Inc.

Unlock clinical trial insights in minutes, not months. Discover a platform that streamlines data review with AI-powered listings and visualizations to empower faster, smarter decisions.

Trials Without Borders: New UK Clinical Trial Regulations

Video | Clinical Leader

The UK is undergoing its most significant overhaul of clinical trials regulations in decades, and U.S. sponsors need to take notice. In this episode of Trials Without Borders, brought to you by Clinical Leader and FlexPoint Bio, host Elena Sinclair and co-host Ross Jackson sit down with UK-based experts to unpack what's changing and where American biotechs most often stumble.

Connect With Clinical Leader: